Hints and tips:
Showing results for BAYER ESSURE
...Investors should not complain about payouts for Essure, which have been adequately provided for in Bayer’s accounts. Opting to settle provides certainty....
...Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, said: “Essure completes Bayer’s portfolio of long-acting intrauterine systems and short-acting oral contraceptives....
...Bayer agreed to buy Conceptus, the maker of the Essure contraceptive procedure, for about $1.1bn in cash in a move that sent the German pharmaceutical group’s share price falling 2 per cent to €79.57....
International Edition